Institute of Genome Research, Vietnam Academy of Science and Technology, Hanoi, Vietnam.
Hanoi Medical University Hospital, Hanoi Medical University, Hanoi, Vietnam.
J Pediatr Endocrinol Metab. 2022 Jul 11;35(9):1206-1210. doi: 10.1515/jpem-2022-0208. Print 2022 Sep 27.
Familial partial lipodystrophy type 2 is the most well-known subtype of lipodystrophy. We describe for the first time the phenotype of a case with lipodystrophy, who carried heterozygous mutation c.G1394A (p.G465D) in the gene.
A 17-year-old girl was diagnosed with FPLD2 due to severe loss of subcutaneous fat in the extremities, buttocks and metabolic complications. However, there was no accumulation of fat over her face and neck, which is remarkably different from the FPLD2 clinical phenotypes. Two years of surveillance showed the challenge due to unable control of insulin resistance, glucose and lipid metabolism. Whole exome sequencing revealed the heterozygous mutation c.1394G>A at exon 11 of gene (p.G465D).
Our case displayed an atypical phenotype of FPLD2 with metabolic anomalies, not cardiovascular diseases. The difficulties of medical management in this case pointed out the urgent need for more effective treatment for individuals suffering from this rare disease.
家族性部分性脂肪营养不良 2 型是最著名的脂肪营养不良亚型。我们首次描述了一例携带基因 c.G1394A(p.G465D)杂合突变的脂肪营养不良患者的表型。
一名 17 岁女孩因四肢、臀部皮下脂肪严重丢失和代谢并发症被诊断为 FPLD2。然而,她的面部和颈部没有脂肪堆积,这与 FPLD2 的临床表型显著不同。两年的监测显示,由于无法控制胰岛素抵抗、葡萄糖和脂质代谢,存在挑战。全外显子组测序显示基因 11 号外显子 c.1394G>A 杂合突变(p.G465D)。
我们的病例表现出代谢异常而非心血管疾病的非典型 FPLD2 表型。该病例的医疗管理困难指出了迫切需要为患有这种罕见疾病的个体提供更有效的治疗。